Sébastien Ronseaux

807 total citations
16 papers, 426 citations indexed

About

Sébastien Ronseaux is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Sébastien Ronseaux has authored 16 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Sébastien Ronseaux's work include Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Click Chemistry and Applications (2 papers). Sébastien Ronseaux is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Click Chemistry and Applications (2 papers). Sébastien Ronseaux collaborates with scholars based in United States, United Kingdom and Switzerland. Sébastien Ronseaux's co-authors include C. Roland Wolf, Colin J. Henderson, Lesley A. McLaughlin, ROBERT FINN, ROBERT FINN, J. Brian Houston, Ian Rosewell, Xinxin Ding, Christa E. Flück and Todd D. Porter and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Sébastien Ronseaux

15 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sébastien Ronseaux United States 11 190 180 151 54 36 16 426
Cameron D. Buchman United States 10 194 1.0× 84 0.5× 106 0.7× 100 1.9× 32 0.9× 11 363
Bryan D. Marks United States 13 244 1.3× 138 0.8× 83 0.5× 10 0.2× 45 1.3× 17 442
Lai Wang China 11 183 1.0× 58 0.3× 145 1.0× 78 1.4× 119 3.3× 17 464
Mariagrazia Distefano Italy 14 374 2.0× 70 0.4× 265 1.8× 77 1.4× 22 0.6× 20 746
Su Sien Ong United States 12 187 1.0× 201 1.1× 200 1.3× 29 0.5× 102 2.8× 15 558
Ryan Jones United States 11 155 0.8× 31 0.2× 142 0.9× 71 1.3× 20 0.6× 24 366
Simon Wong United States 13 228 1.2× 118 0.7× 100 0.7× 34 0.6× 77 2.1× 24 438
Tiffany Cho Canada 9 197 1.0× 77 0.4× 178 1.2× 25 0.5× 5 0.1× 15 423
Pablo Cano Canada 9 127 0.7× 130 0.7× 283 1.9× 153 2.8× 11 0.3× 12 544
Kenneth C. Cassidy United States 12 205 1.1× 69 0.4× 70 0.5× 35 0.6× 28 0.8× 34 474

Countries citing papers authored by Sébastien Ronseaux

Since Specialization
Citations

This map shows the geographic impact of Sébastien Ronseaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sébastien Ronseaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sébastien Ronseaux more than expected).

Fields of papers citing papers by Sébastien Ronseaux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sébastien Ronseaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sébastien Ronseaux. The network helps show where Sébastien Ronseaux may publish in the future.

Co-authorship network of co-authors of Sébastien Ronseaux

This figure shows the co-authorship network connecting the top 25 collaborators of Sébastien Ronseaux. A scholar is included among the top collaborators of Sébastien Ronseaux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sébastien Ronseaux. Sébastien Ronseaux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Milgram, Benjamin C., Natasja Brooijmans, Jack A. Henderson, et al.. (2025). Discovery of STX-721, a Covalent, Potent, and Highly Mutant-Selective EGFR/HER2 Exon20 Insertion Inhibitor for the Treatment of Non-Small Cell Lung Cancer. Journal of Medicinal Chemistry. 68(3). 2403–2421.
2.
Chuntova, Pavlina, Akane Yamamichi, Rohini Narayanaswamy, et al.. (2022). Inhibition of D-2HG leads to upregulation of a proinflammatory gene signature in a novel HLA-A2/HLA-DR1 transgenic mouse model of IDH1R132H-expressing glioma. Journal for ImmunoTherapy of Cancer. 10(5). e004644–e004644. 23 indexed citations
4.
Zhang, Meng, Angelo Aguilar, Shilin Xu, et al.. (2021). Discovery of M-1121 as an Orally Active Covalent Inhibitor of Menin-MLL Interaction Capable of Achieving Complete and Long-Lasting Tumor Regression. Journal of Medicinal Chemistry. 64(14). 10333–10349. 16 indexed citations
5.
Shi, Lei, Juan Dubrot, Christine C. Hudson, et al.. (2020). Abstract 1810: The mutant IDH1 inhibitor ivosidenib promotes tumor cell differentiation and anti-tumor immunity in intrahepatic cholangiocarcinoma. Cancer Research. 80(16_Supplement). 1810–1810. 1 indexed citations
6.
7.
Cathelin, Séverine, David Sharon, Dan Cojocari, et al.. (2018). Combination of Enasidenib and Venetoclax Shows Superior Anti-Leukemic Activity Against IDH2 Mutated AML in Patient-Derived Xenograft Models. Blood. 132(Supplement 1). 562–562. 23 indexed citations
9.
Ronseaux, Sébastien, Christophe Clément, & Essaïd Ait Barka. (2013). Interaction of Ulocladium atrum, a Potential Biological Control Agent, with Botrytis cinerea and Grapevine Plantlets. SHILAP Revista de lepidopterología. 3(4). 632–647. 12 indexed citations
10.
Henderson, Colin J., Lesley A. McLaughlin, ROBERT FINN, et al.. (2013). A Role for Cytochrome b5 in the In Vivo Disposition of Anticancer and Cytochrome P450 Probe Drugs in Mice. Drug Metabolism and Disposition. 42(1). 70–77. 17 indexed citations
11.
McCarthy, Anna R., Lisa Pirrie, Jonathan J. Hollick, et al.. (2012). Synthesis and biological characterisation of sirtuin inhibitors based on the tenovins. Bioorganic & Medicinal Chemistry. 20(5). 1779–1793. 50 indexed citations
12.
Riddick, David S., Xinxin Ding, C. Roland Wolf, et al.. (2012). NADPH–Cytochrome P450 Oxidoreductase: Roles in Physiology, Pharmacology, and Toxicology. Drug Metabolism and Disposition. 41(1). 12–23. 110 indexed citations
13.
Niemira, Magdalena, Agata Kot‐Wasik, Sébastien Ronseaux, et al.. (2011). The Imidazoacridinone Antitumor Drug, C-1311, Is Metabolized by Flavin Monooxygenases but Not by Cytochrome P450s. Drug Metabolism and Disposition. 39(8). 1423–1432. 20 indexed citations
14.
McLaughlin, Lesley A., Sébastien Ronseaux, ROBERT FINN, Colin J. Henderson, & C. Roland Wolf. (2010). Deletion of Microsomal Cytochrome b5 Profoundly Affects Hepatic and Extrahepatic Drug Metabolism. Molecular Pharmacology. 78(2). 269–278. 60 indexed citations
15.
Staples, Oliver, Jonathan J. Hollick, Johanna Campbell, et al.. (2008). Characterization, chemical optimization and anti-tumor activity of a tubulin poison identified by a p53-based phenotypic screen. Cell Cycle. 7(21). 3417–3427. 12 indexed citations
16.
FINN, ROBERT, Lesley A. McLaughlin, Sébastien Ronseaux, et al.. (2008). Defining the in Vivo Role for Cytochrome b5 in Cytochrome P450 Function through the Conditional Hepatic Deletion of Microsomal Cytochrome b5. Journal of Biological Chemistry. 283(46). 31385–31393. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026